Selective Stabilization and Destabilization of Protein Domains in Tissue-Type Plasminogen Activator Using Formulation Excipients. (2019)
Attributed to:
Elucidating aggregation mechanisms in antibody fragment-based therapeutics to improve their manufacturability
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acs.molpharmaceut.8b01024
PubMed Identifier: 30565948
Publication URI: http://europepmc.org/abstract/MED/30565948
Type: Journal Article/Review
Volume: 16
Parent Publication: Molecular pharmaceutics
Issue: 2
ISSN: 1543-8384